Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade-Reference-Cited by-同舟云学术

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Published:2017-09 Issue:6 Volume:170 Page:1120-1133.e17
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Wei Spencer C.,Levine Jacob H.,Cogdill Alexandria P.,Zhao Yang,Anang Nana-Ama A.S.,Andrews Miles C.,Sharma Padmanee,Wang Jing,Wargo Jennifer A.,Pe’er Dana,Allison James P.

Funder

NCI Cancer Center Support Grant

Cancer Prevention and Research Institute of Texas

MDACC CCSG Bioinformatics Shared Resource

NIH

MSK Cancer Center Support Grant/Core Grant

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference58 articles.

1. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia;Amir;Nat. Biotechnol.,2013

2. Single-cell mass cytometry adapted to measurements of the cell cycle;Behbehani;Cytometry A,2012

3. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum;Bendall;Science,2011

4. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion;Bengsch;Immunity,2016

5. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J. Clin. Oncol.,2010

Cited by 986 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology;Current Pharmaceutical Biotechnology;2024-11

2. Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer;Biomedicine & Pharmacotherapy;2024-10

3. Complete Cure of Inoperable Stage IV Locally Advanced Hypopharyngeal Squamous Cell Carcinoma by an Innovative Combination Cancer Immunotherapy Consisting of Radiation, Immune Checkpoint Inhibitors, and Dendritic Cell Vaccine;Cureus;2024-09-14

4. Microdissection tools to generate organoids for modeling the tumor immune microenvironment;Microsystems & Nanoengineering;2024-09-10

5. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09